Sterile Injectables Market Research Report Now Available at Acute Market Reports

PR Comments Off on Sterile Injectables Market Research Report Now Available at Acute Market Reports

Sterile Injectables Market (Drug Type: Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others; Therapeutic Area: Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others)- Growth, Future Prospects and Competitive Analysis, 2017-2025, the global sterile injectables market was evaluated at US$ 324.1 Bn in 2016, expanding at a CAGR of 7.1%.

Browse Full Report here

Market Insights:
Injectables are administered into the blood stream to ensure rapid recovery, convenience to patients and reduced complications. Sterile injectables are preferred in medical treatment due to its rapid mode of action, simple administration approach and non-interference with digestive system. The prolonged effect of injectables with lower dosage and increasing bioavailability has also contributed to rise in demand for sterile injectables.
Harbouring innovations in new product development with advanced technologies resulting in improved drug delivery techniques, emerging preference of usage of biologics and their swift adoption among healthcare professionals have driven the sterile injectables market. However, high operational cost and stringent guidelines regarding to the quality, safety and efficacy of the products have a negative effect on the growth of sterile injectables market. Increasing focus on merger and acquisition activities of major players with a view to improved commercialization and expanding R&D expenditure are further driving the sterile injectables market.

On the basis of drug type, monoclonal antibody is estimated to be the leading segment as a result of increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases and autoimmune diseases like rheumatoid arthritis and its effective therapeutic effect. Out of all the therapeutic areas of sterile injectables, cancer and infectious diseases are considered to hold the largest share due to increasing cases across the globe consequent of improved clinical outcomes.

Browse the complete report at

Geographically, in the year 2016, North America spearheaded the sterile injectables market with a steady growth due to growing prevalence of chronic disorders, developed healthcare infrastructure, adoption of advanced technology, growing health awareness among patients, presence of key manufacturers and destination of outsourcing of sterile injectables. Europe is anticipated to be largely driven by improved product development and increasing demand and growing focus on contract manufacturing. Asia Pacific is predicted to witness the fastest growth as a result of growing consumer awareness, emerging market players and developing healthcare infrastructure.
The sterile injectables market presently comprises various companies having their products marketed. The key industry players include Pfizer Inc., Mylan N.V, Baxter International Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Amgen Limited, Nichi-Iko Pharmaceutical Co., Sanofi, Eli Lilly, AstraZeneca plc., and Company and other notable players.

Download Free Request Sample:

Table of Content:

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sterile Injectables Market Portraiture
2.1.1. Global Sterile Injectables Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Sterile Injectables Market, by Therapeutic Area, 2016 (US$ Mn)
2.1.3. Global Sterile Injectables Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Sterile Injectables Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Sterile Injectables: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 7. Company Profiles
7.1. Amgen Limited
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. AstraZeneca plc.
7.3. Baxter International, Inc.
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services, Inc.
7.6. Merck & Co., Inc.,
7.7. Mylan N.V.
7.8. Nichi-Iko Pharmaceutical Co.
7.9. Novartis AG
7.10. Pfizer, Inc.
7.11. Sanofi

About – Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:

Name: Chris Paul


Designation: Global Sales Manager

Toll Free (US/CANADA): +1-855-455-8662




Back to Top